Shakelford Pharma Inc. SUBSCRIPTION AGREEMENT SIGNATURE PAGESubscription Agreement • July 20th, 2020 • Shackelford Pharma Inc. • Pharmaceutical preparations • California
The undersigned, desiring to purchase of Shakelford Pharma Inc. by executing this signature page, hereby executes, adopts and agrees to all terms, conditions and representations of the Subscription Agreement.
SHACKELFORD PHARMA INC. PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT INSTRUCTIONS TO SUBSCRIBERPrivate Placement Subscription Agreement • December 9th, 2022 • Shackelford Pharma Inc. • Pharmaceutical preparations • British Columbia
The undersigned (the "Subscriber") hereby irrevocably subscribes for and agrees to purchase from Shackelford Pharma Inc. (the "Issuer") that number of voting common shares of the Issuer (the "Shares") set out below at a price of $1.50 per Share (the "Offering"). The Subscriber must invest a minimum of $1,500.00; however, the Issuer reserves the right to waive this minimum in its sole discretion. The Subscriber agrees to be bound by the terms and conditions set forth in the attached "Terms and Conditions of Subscription for Shares".
Broker-Dealer AgreementBroker-Dealer Agreement • June 11th, 2020 • Shackelford Pharma Inc. • Pharmaceutical preparations
This agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Shackelford Pharma Inc. (“Client”), a Vancouver, British Columbia Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of May 27, 2020(the “Effective Date”):
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
VOTING AGREEMENT LEGAL_1:49991946.2Voting Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
THIS VOTING AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2018 by and among Shackelford Pharma Inc., a corporation existing under the Business Corporations Act (British Columbia) (the “Company”) and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Section 6.1 or 6.2) (the “Shareholders”).
August 1, 2019 Private and Confidential Geoff Griffiths North Vancouver, BC V7R 1J8 Dear Geoff:Shackelford Pharma Inc. • May 4th, 2020 • British Columbia
We are pleased to offer you employment in the position of Director of Commercialization with Shackelford Pharma Inc. (hereinafter “SPI”) on the terms and conditions set out in this letter agreement (the “Agreement”). This offer of employment and its terms are subject to the company closing its current round of financing and the provision of three references acceptable to SPI.
SHACKELFORD PHARMA INC. SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
THIS SHAREHOLDER RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2018, by and among Shackelford Pharma Inc., a corporation existing under the Business Corporations Act (British Columbia) (the “Company”) and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Sections 3.1, 5.1 or 5.13) (the “Shareholders”).
SHACKELFORD PHARMA INC. RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTSale Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
THIS RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (the “Agreement”) is made as of June 19, 2018 by and among Shackelford Pharma Inc., a corporation existing under the Business Corporations Act (British Columbia) (the “Company”) and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Section 6.10 or 6.12) (the “Shareholders”).
SHACKELFORD PHARMA INC. RESTRICTED SHARE PURCHASE AGREEMENTRestricted Share Purchase Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
THIS RESTRICTED SHARE PURCHASE AGREEMENT (this "Agreement") is made as of June 19, 2018 (the "Effective Date") by and between Shackelford Pharma Inc. (the "Company"), a corporation existing under the Business Corporations Act (British Columbia) (the "Act"), and [⬤] (the "Purchaser").
EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • July 20th, 2020 • Shackelford Pharma Inc. • Pharmaceutical preparations
This Agreement is entered into as of this ___ day of ______, 2020 (the "Effective Date"), by and between Ramot at Tel Aviv University Ltd., a company organized under the laws of Israel, having a place of business in Ramat-Aviv, Tel Aviv 6139201, Israel ("Ramot") and Shackelford Pharma Inc., having a place of business at Suite 2300 - 1177 West Hastings Street, Vancouver, British Columbia, Canada V6E 4T5 ("Company"). Ramot and the Company shall be referred to individually as "Party" and collectively as "Parties".
INDEPENDENT CONTRACTOR AGREEMENTIndependent Contractor Agreement • May 4th, 2020 • Shackelford Pharma Inc. • British Columbia
WHEREAS the Company wishes to retain the Contractor as an independent contractor to provide certain services to the Company, on the terms and conditions set forth in this Agreement.
